Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Novan, Inc.

NOVNNASDAQ
Healthcare
Biotechnology
$0.09
$-0.03(-24.84%)
U.S. Market opens in 15h 0m

Novan, Inc. (NOVN) Stock Overview

Explore Novan, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6M
P/E Ratio-0.11
EPS (TTM)$-0.84
ROE-1.71%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

NOVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novan, Inc. (NOVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.11 and a market capitalization of 2.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
54.26%
1-Month Change
-24.84%
3-Month Change
-92.16%
6-Month Change
-93.08%
Year-to-Date (YTD) Change
-94.33%
1-Year Change
-96.41%
3-Year Change
-97.91%
5-Year Change
-99.67%
All-Time (Max) Change
-99.95%

Contact Information

919 485 8080
4020 Stirrup Creek Drive, Durham, CA, 27703

Company Facts

900 Employees
IPO DateSep 21, 2016
CountryUS

Frequently Asked Questions